Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by:
Aptium Oncology Research Network
ClinicalTrials.gov Identifier:
NCT00516100
First received: August 10, 2007
Last updated: January 14, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)